# Orthobiological Therapies in Musculoskeletal Disorders

> **NCT07434115** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **PROREGEN** · enrollment: 300 (estimated)

## Conditions studied

- Musculoskeletal Diseases or Conditions

## Interventions

- **BIOLOGICAL:** PRP injection
- **BIOLOGICAL:** Bone Marrow Concentrate (BMAC)
- **BIOLOGICAL:** Hyaluronic Acid (Viscosupplementation)
- **BIOLOGICAL:** Nanofat

## Key facts

- **NCT ID:** NCT07434115
- **Lead sponsor:** PROREGEN
- **Sponsor class:** NETWORK
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-30
- **Primary completion:** 2029-01
- **Final completion:** 2030-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07434115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07434115, "Orthobiological Therapies in Musculoskeletal Disorders". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT07434115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*